Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1533-1540

  Lysle, Donald T ^a   Hoffman, Kathryn E ^a   Dykstra, Linda A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; CONCANAVALIN A; CYTOKINE; DRUG VEHICLE; GAMMA INTERFERON; INTERLEUKIN 2; IONOMYCIN; KETAMINE; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; MORPHINE; OPIATE RECEPTOR; PHYTOHEMAGGLUTININ; XYLAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN LATERAL VENTRICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNE STATUS; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MICROINJECTION; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CAUDATE NUCLEUS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; LYMPHOCYTES; MALE; MORPHINE; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR;

EID: 0030440906     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ADER, R., FELTEN, D. AND COHEN, N.: Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30: 561, 1990.
2. BAYER, B. M., DAUSSIN, S., HERNANDEZ, M. AND IRVIN, L.: Morphine inhibition of lymphocyte activity is mediated by an opioid-dependent mechanism. Neuropharmacology 29: 369, 1990.
3. BEITZ, A. J.: The nuclei of origin of brainstem serotonergic projections to the rodent spinal trigeminal nucleus. Neurosci. Lett. 32: 223, 1987.
4. BRYANT, H. U. BERNTON, E. W. AND HOLADAY, J. W.: Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41: 1731, 1987.
5. BRYANT, H. U., BERTON, E. W. AND HOLADAY, J. W.: Morphine pellet-induced immunomodulation in mice: Temporal relationships. J. Pharmacol. Exp. Ther. 245: 913, 1988.
6. CASELLA, A. M., GUARDIOLA, H. AND RENAUD, F. L.: Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 18: 35, 1991.
7. DONAHOE, R. M., NICHOLSON, J. K. A., MADDEN, J. J., DONAHOE, F., SHAFER, D. A., GORDON, D., BOKOS, P. AND FALEK, A.: Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41: 254-264, 1986.
8. FECHO, K., MASLONEK, K. A., DYKSTRA, L. A. AND LYSLE, D. T.: Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276: 626-636, 1996.
9. FELTEN, D. L., FELTEN, S. Y., BELLINGER, D. L., CARLSON, S. L., ACKERMAN, K. D., MADDEN, K. S., OLSCHOWKI, J. A. AND LIVNAT, S.: Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol. Rev. 100: 225, 1987.
10. HERNANDEZ, M. C., FLORES, L. R. AND BAYER, B. M.: Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267: 1336, 1993.
11. HUNG, C. Y., LEFKOWITZ, S. S. AND GEBER, W. F.: Interferon inhibition by narcotic analgesics. Proc. Soc. Exp. Biol. Med. 142: 106-111, 1973.
12. HUSSEY, H. H. AND KATZ, S.: Infections resulting from narcotic addiction: Report of 102 casss. Am. J. Med. 9: 186-193, 1950.
13. JAFFE, J. H. AND MARTIN, W. R.: Opioid analgesics and antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, T. W. Rail, A. S. Nies and P. Taylor, pp. 485-521, Pergamon Press, New York, 1990.
14. JESSOP, J. J. AND TAPLITS, M. S.: Effects of high doses of morphine on Con-A induced lymphokine production in vitro. Immunopharmacology 22: 175, 1991.
15. JOSEPH, D. B. AND BIDLACK, J. M.: The kappa-opioid receptor expressed on the mouse lymphoma cell line R1.1 contains a sulfhydryl group at the binding site. Eur. J. Pharmacol. 267: 1, 1994.
16. LAWRENCE, D. M., JOSEPH, D. B. AND BIDLACK, J. M.: Kappa opioid receptors expressed on three related thymoma cell lines: Differences in receptor-effector coupling. Biochem. Pharmacol. 49: 81, 1995.
17. LEFKOWITZ, S. S. AND CHIANG, C. Y.: Effects of certain abused drugs on hemolysin forming cells. Life Sci. 17: 1763-1767, 1975.
18. LOURIA, D. B., HENSLE, T. AND ROSE, J.: The major medical complication of heroin addiction. Ann. Intern. Med. 67: 1-27, 1967.
19. LUTTGENS, W. F.: Endocarditis in "main line" opium addicts. Arch. Intern. Med. 83: 653-664, 1949.
20. LYSLE, D. T., COUSSONS, M. E., WATTS, V. J., BENNETT, E. H. AND DYKSTRA, L. A.: Morphine-induced alterations of immune status: Dose-dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265: 1071, 1993.
21. MA, Q. AND HAN, J.: Neurochemical and morphological evidence of an antinociceptive neural pathway from the nucleus raphe dorsalis to nucleus accumbens in the rabbit. Brain Res. Bull. 28: 931, 1992.
22. MADDEN, J. J., DONAHOE, R. M., ZWEMER-COLLINS, J., SHAFER, D. A. AND FALEK, A.: Binding of naloxone to human T-lymphocytes. Biochem. Pharmacol. 36: 4103-4109, 1987.
23. MANSOUR, A., FOX, C. A., THOMPSON, R. C., AKIL, H. AND WATSON, S. J.: μ-Opioid receptor mRNA expression in the rat CNS: Comparison to μ-receptor binding. Brain Res. 643: 245-265, 1994.
24. MCDONOUGH, R. J., MADDEN, J. J., FALEK, A., SHAFER, D. A., PLINE, M., GORDON., D., BOKOS, P., KUEHNIE., J. C. AND MENDELSON, J.: Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes. J. Immunol. 125: 2539-2543, 1980.
25. MEHRISHI, J. N. AND MILLS, I. H.: Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27: 240, 1983.
26. NOVICK, D. M., OCHSHORN, M., GHALI, V., CROXSON, T. S., MERCER, W. D., CHIORAZZI, N. AND KREEK, M. J.: Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther., 250: 606-610, 1989.
27. OCHSHORN, M., NOVICK, D. M. AND KREEK, M. J.: In vitro studies of the effects of methadone on natural killer cell activity. Isr. J. Med. Sci. 26: 421-425, 1990.
28. OVADIA, H., NITSAN, P. AND ABRAMSKY, O.: Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 21: 93, 1989.
29. PAXINOS, G. AND WATSON, C.,: The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
30. PETERSON, P. K., SHARP, B., GEKKER, G. AND KEANE, W. F.: Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol. 138: 3907, 1987.
31. ROJAVIN, M., SZABO, I., BUSSIERE, J. L., ROGERS, T. J., ADLER, M. W. AND EISENSTEIN, T. K.: Morphine treatment in-vitro or in-vivo decreases phagocytic functions of murine macrophages. Life Sci. 53: 997, 1993.
32. SHAVIT, Y., DEPAULIS, A., MARTIN, F. C., TERMAN, G. W., PECHNICK, R. N., ZANE, C. J., GALE, R. P. AND LIEBESKIND, J. C.: Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83: 7114, 1986.
33. SHAVIT, Y., MARTIN, F. C., YIRMIYA, R., BEN-ELIYAHU, S., TERMAN, G. W., WEINER, H., GALE, R. P. AND LIEBESKIND, J. C.: Effects of a single administration of morphine or foot shock stress on natural killer cell cytotoxicity Brain Behav. Immun, 1: 318, 1987.
34. WEBER, R. J. AND PERT, A.: The periaqueductal grey matter mediates opiateinduced immunosuppression. Science 245: 188, 1989.
35. WYBRAN, J., APPELBOOM, FAMEY, J. P. AND GOVAERTS, A.: Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. J. Immunol. 123: 1068-1070, 1979.
36. YAKSH, T. L., YEUNG, J. C. AND RUDY, T. A.: Systemic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 114: 83, 1976.